How we began: We began as a conversation about seeds in 1977. Four and a half decades later, we are still talking about seeds, but the world has grown infinitely more complex: new technologies have developed, economies have globalized, multinational companies have expanded their reach, and wealth and capital are concentrated in the hands of fewer and fewer giant corporations. Life itself has been manipulated, picked apart, re-assembled – and then patented.
In addition to esthetical criteria I based my choice on symbols which conveyed the impression of loose particles freely dispersing. I indeed believe that the main worry comes from material that can easily disperse and thus easily enter the human body. It should be noted that even if particles are initially embedded in a media, great care has to be taken to assess the whole cycle of life of the product so that even when it is disposed of the nano-particulate remain trapped.
Enviado por ETC Staff el
Presentation of Kathy Jo Wetter on behalf of ETC Group
Thank you for the opportunity to present the views of ETC Group. We are an international civil society organization based in Canada. Our work focuses on the social and economic impacts of emerging technologies and their implications, especially for marginalized communities. I’m based in ETC Group’s North Carolina office.
Enviado por ETC Staff el
During summer vacation 2006, the lead US environmental regulatory agency acknowledged it has approved at least 15 novel nano-scale chemicals. Earlier this year EPA sanctioned the unproven use of iron nanoparticles to clean up a pesticide dump.
Enviado por ETC Staff el
El verano pasado (2006), la Agencia de protección al ambiente de Estados Unidos dio luz verde a 15 productos químicos nanoescalares, aunque anteriormente había sancionado el uso de nanopartículas para limpiar un tiradero de plaguicidas y había prometido consultar con el público la regulación de los productos.
Enviado por Kathy Jo Wetter el
On October 10, ETC Group attended the US Food and Drug Administrations first public meeting on nanotechnology. About 40 people had signed up to make presentations, and we were each given eight minutes to say our piece to the FDAs newly-formed Nanotechnology Task Force. (You can read the text of ETC Groups presentation here.)
Enviado por Charlie el
Nano-Drug's Dirty Little Secret
Enviado por ETC Staff el
Asunto: Las aplicaciones médicas de las tecnologías nanoescalares tienen el potencial de revolucionar el cuidado de la salud al brindar poderosas herramientas para diagnosticar y tratar las enfermedades desde un nivel molecular. Sin embargo, el celo actual en pos de tratamientos potenciados a nivel nanométrico puede desviar los escasos fondos destinados a la investigación y el desarrollo de la medicina y de los servicios esenciales de salud, disminuyendo los recursos directos destinados a los aspectos no médicos de la salud y el bienestar comunitarios. Aunque se proclama que la medicina nanológica es una solución a las urgentes necesidades de salud en el Sur global, en realidad surge del Norte y la diseñan primordialmente para los mercados ricos. El fin último de que la industria farmacéutica utilice tecnologías nanoescalares es hacer que todas las personas se vuelvan pacientes y que todo paciente sea un cliente que pague por “medicar” sus afecciones sociales con drogas y dispositivos que mejoren el desempeño humano. Los fármacos y dispositivos habilitados nanológicamente podrían conducir a una era con dos niveles de humanos —el Homo sapiens y el Homo sapiens 2.0.
Enviado por ETC Staff el
Issue: Medical applications of nano-scale technologies have the potential to revolutionize healthcare by delivering powerful tools for diagnosing and treating disease at the molecular level. But the current zeal for nano-enabled
medicines could divert scarce medical R&D funds away from essential health services and direct resources away from non-medical aspects of community health and wellbeing. Although nanomedicine is being touted as a solution to pressing health needs in the global South, it is being driven from the North and is designed primarily for wealthy markets. Using nano-scale technologies, the pharmaceutical industry’s ultimate goal is to make every person a patient and every patient a paying customer by “medicating” social ills with human performance enhancement (HyPE) drugs and devices. Nanoenabled HyPEs could usher in an era of two-tiered humans – Homo sapiens and Homo sapiens 2.0.
Enviado por Silvia Ribeiro el
On September 12 just days before Mexico celebrates its Independence Day ETC Group and several Mexican organizations held a press conference in Mexico City and declared the traditional Cry of Independence, but this time for the genetic independence of Mexican maize. It has been over five years since DNA from genetically modified maize contaminated native maize varieties in Mexico.
Enviado por Jim Thomas el
The Economist this week has a Special Report on Synthetic Biology , the new field of building artificial life forms from scratch. As is to be expected from the Economist, this is a fairly upbeat assesment of the technology that fails to mention the growing opposition to Synthetic Biology, signalled a few months ago when almost forty civil society groups, trade unions and scientific associations signed an open letter calling for caution.
Here at ETC we have been busy writing our own special report on Synthetic Biology (which we are calling 'Extreme Genetic Engineering' - watch this space!). You can expect it to be a bit more critical than the Economist.
Enviado por ETC Staff el
Enviado por ETC Group el
Enviado por ETC Staff el
Siguiendo con la expansión de su imperio corporativo en semillas —Monsanto, la empresa semillera más grande del mundo—anunció ayer que adquirirá por 1500 millones de dólares la mayor empresa de semillas de algodón del globo, Delta & Pine Land, basada en Mississippi (Estados Unidos). Juntos, Monsanto y Delta & Pine Land (D&PL) controlan más del 57% del mercado de semillas de Estados Unidos. Con las subsidiarias de D&PL en 13 países —incluyendo grandes mercados como China, India, Brasil, México, Turquía y Paquistán— esta operación significa que Monsanto tendrá una posición dominante en una de las commodities más importantes del comercio agrícola, y que millones de agricultores de algodón sufrirán una mayor presión para que aceptar semillas de algodón transgénico.
Enviado por ETC Staff el
In a quest to expand its corporate seed empire - Monsanto, the world's largest seed enterprise - announced yesterday that it will buy the world's leading cotton seed company, Mississippi-based (USA) Delta & Pine Land, for US$1.5 billion. Monsanto and Delta & Pine Land (D&PL) together account for over 57% of the US cotton seed market. With D&PL subsidiaries in 13 countries - including major markets such as China, India, Brazil, Mexico, Turkey and Pakistan - the takeover means that Monsanto will command a dominant position in one of the world's most important agricultural trade commodities and that millions of cotton farmers will be under increased pressure to accept genetically modified (GM) cottonseed.
Enviado por ETC Staff el
Dans sa quête d’un empire toujours plus vaste, Monsanto – la plus grosse semencière au monde – a annoncé hier son intention d’acheter pour 1,5 milliard $US la firme Delta & Pine Land, numéro un mondial des semences de coton établie dans le Mississipi (É.-U.). Ensemble, Monsanto et Delta & Pine Land (D&PL) contrôlent plus de 57 % du marché des semences de coton aux É.-U. D&PL a des filiales dans 13 pays, dont certains grands marchés du coton – Chine, Inde, Brésil, Turquie, Pakistan. Cette prise de contrôle assure à Monsanto une position dominante dans le commerce de l’un des produits agricoles majeurs dans le monde.Cela veut aussi dire que des millions d’agriculteurs seront soumis à des pressions encore plus importantes pour adopter les semences de coton génétiquement modifiées (GM).
Enviado por Silvia Ribeiro el
By Silvia Ribeiro This article provides more information about the infamous case of two new experimental drugs derived from transgenic rice by Ventria Biosciences, tested without consent, on babies and children hospitalized at two pediatric institutes in Peru. The rice was genetically engineered with synthetic human genes to produce artificial human milk proteins. (Only spanish).
Enviado por Kathy Jo Wetter el
Silvia Ribeiro*
The biotech company Ventria Biosciences sponsored tests, on babies and children hospitalized at two pediatric institutes in Peru, of two new experimental drugs derived from transgenic rice that was genetically engineered with synthetic human genes to produce artificial human milk proteins.
Enviado por ETC Staff el
Dos proyectos del Banco Mundial, a través del Fondo Mundial para el Medio Ambiente (GEF por sus siglas en inglés),proponen introducir variedades transgénicas de cultivos como maíz, papa, yuca, arroz y algodón en cinco países latinoamericanos y cuatro africanos, que son centros de origen o diversidad de éstos y otros importantes cultivos básicos. Organizaciones de la sociedad civil advierten que la contaminación transgénica a que se expone a cultivos fundamentales para las economías campesinas es un riesgo inaceptable. Los multimillonarios proyectos son promovidos bajo el disfraz de investigación científica en bioseguridad, pero las organizaciones de ambos continentes llaman a su inmediato rechazo ya que amenazan la soberanía alimentaria y los sistemas de semillas campesinos.
Para saber más sobre el Grupo ETC o para contactarnos.
